WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006087419) A METHOD FOR ADMINISTERING LEVOSIMENDAN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/087419    International Application No.:    PCT/FI2006/000056
Publication Date: 24.08.2006 International Filing Date: 17.02.2006
IPC:
A61K 31/50 (2006.01), A61K 31/00 (2006.01), A61P 9/04 (2006.01), A61P 9/12 (2006.01), A61P 9/10 (2006.01), A61P 9/00 (2006.01), A61P 11/00 (2006.01)
Applicants: ORION CORPORATION [FI/FI]; Orionintie 1, FI-02200 Espoo (FI) (For All Designated States Except US).
ABBOTT LABORATORIES [US/US]; 100 Abbott Park Road, Abbott Park, IL 60064-3500 (US) (For All Designated States Except US).
PADLEY Robert [US/US]; (US) (For US Only).
THAKKAR Roopal [US/US]; (US) (For US Only).
KIVIKKO, Matti [FI/FI]; (FI) (For US Only).
DELGADO-HERRERA Leticia [US/US]; (US) (For US Only)
Inventors: PADLEY Robert; (US).
THAKKAR Roopal; (US).
KIVIKKO, Matti; (FI).
DELGADO-HERRERA Leticia; (US)
Agent: ORION CORPORATION ORION PHARMA; Legal Affairs and Intellectual Property Rights, P.O. Box 65, FI-02101 Espoo (FI)
Priority Data:
60/654,087 18.02.2005 US
Title (EN) A METHOD FOR ADMINISTERING LEVOSIMENDAN
(FR) METHODE D'ADMINISTRATION DE LEVOSIMENDAN
Abstract: front page image
(EN)The invention relates to intermittent administration of an inotropic agent (such as, but not limited to a levosimendan compound) or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders, such as, pulmonary hypertension, myocardial ischemia, acute heart failure, chronic heart failure or acute on chronic heart failure.
(FR)L'invention concerne l'administration intermittente d'un agent inotrope (comme par exemple, mais sans en exclure d'autres, un composé à base de levosimendan) ou d'un sel de qualité pharmaceutique de cet agent inotrope, pour le traitement de troubles cardiovasculaires, tels que l'hypertension artérielle pulmonaire, l'ischémie myocardique, l'insuffisance cardiaque aiguë, l'insuffisance cardiaque chronique ou l'insuffisance cardiaque aiguë sur chronique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)